Orford Keith 4
4 · Calithera Biosciences, Inc. · Filed Feb 24, 2020
Insider Transaction Report
Form 4
Orford Keith
SR. VP, CLINICAL DEVELOPMENT
Transactions
- Sale
Common Stock
2020-02-20$8.00/sh−3,021$24,168→ 8,541 total
Footnotes (1)
- [F1]Reported transaction occurred pursuant to a Rule10b5-1 Trading Plan.